A controlled hematoxylin-eosin for actinic elastosis-lysis. Its versatility and use for vascular damage (actinic arteriopathy) in the skin and orbit.
To demonstrate elastic tissue and its reactions in the skin and other organs, the hematoxylin-eosin staining method had been modified in two ways: (a) the hematoxylin solution is used once only to obtain its full potential, and (b) aqueous eosin is given greater selectivity by controlling its pH with a buffer. This stain highlights the broad supporting role of elastic tissue, particularly in pressure-containing blood vessels. It also helps to define the hyperplasia, degeneration, and elastolysis that arise from its peculiar sensitivity to actinic radiation.
O'Brien
J P
JP
Pathology Laboratory, Wales Medical Centre, Sydney, Australia.
D001158:Arteries / Q000473:pathology; D002114:Calcinosis / Q000473:pathology; D004547:Elastic Tissue / Q000098:blood supply / Q000473:pathology*; D004801:Eosine Yellowish-(YS) / Q000008:administration & dosage; D013700:Giant Cell Arteritis / Q000473:pathology; D006416:Hematoxylin / Q000008:administration & dosage; D006801:Humans; D009915:Orbit / Q000098:blood supply / Q000473:pathology*; D012867:Skin / Q000098:blood supply / Q000473:pathology*; D015595:Skin Aging / Q000473:pathology; D013194:Staining and Labeling / Q000379:methods; D013699:Temporal Arteries / Q000473:pathology
D004801:Eosine Yellowish-(YS); D006416:Hematoxylin